Skip to main content

Andera Partners participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches

Written by Kai Schmitz on . Posted in Client News.